Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
16.00
+0.55 (3.56%)
At close: Sep 26, 2025, 4:00 PM EDT
16.01
+0.01 (0.06%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Amarin Corporation Employees
Amarin Corporation had 275 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
275
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$797,676
Profits / Employee
-$376,684
Market Cap
330.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMRN News
- 27 days ago - Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025 - GlobeNewsWire
- 4 weeks ago - New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups - GlobeNewsWire
- 4 weeks ago - New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025 - GlobeNewsWire
- 2 months ago - Amarin Corporation plc (AMRN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Amarin Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025 - GlobeNewsWire
- 3 months ago - RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE - GlobeNewsWire
- 5 months ago - Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript - Seeking Alpha